Mechanical Circulatory Support for Peripartum Cardiomyopathy: A Systematic Review

Blumer, Vanessa; Arcay, Luis; Mendirichaga, Rodrigo; Chaparro, Sandra

doi:10.1016/j.cardfail.2017.07.357

Cited by 4 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…MCS devices are used in CS with severe hemodynamic compromise refractory to medical therapy, sometimes as a bridge to a durable VAD or HT. 40 , 41 The evidence on the association of MCS use compared with medical therapy with mortality in PPCM is variable and limited by small observational studies, case series, and reports. 42 , 43 , 44 , 45 , 46 , 47 , 48 We found worse mortality outcomes in Black and Hispanic patients compared with White patients, despite relatively higher MCS utilization rates.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Racial and Ethnic Disparities in the Trends and Outcomes of Cardiogenic Shock Complicating Peripartum Cardiomyopathy

et al. 2022

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

“…MCS devices are used in CS with severe hemodynamic compromise refractory to medical therapy, sometimes as a bridge to a durable VAD or HT . The evidence on the association of MCS use compared with medical therapy with mortality in PPCM is variable and limited by small observational studies, case series, and reports .…”

Section: Discussionmentioning

confidence: 99%

Racial and Ethnic Disparities in the Trends and Outcomes of Cardiogenic Shock Complicating Peripartum Cardiomyopathy

et al. 2022

View full text Add to dashboard Cite

Peripartum Cardiomyopathy

Goland¹,

Elkayam²

2019

Cardiac Problems in Pregnancy, 4th Edition

View full text Add to dashboard Cite

Mechanical circulatory support for cardiogenic shock during the peripartum period

Elad,

Karas,

Changhee

et al. 2024

Artificial Organs

View full text Add to dashboard Cite

BackgroundCardiomyopathies account for more than half of the cardiovascular disease during the peripartum period. In the extreme, patients may present with cardiogenic shock (CS) requiring mechanical circulatory support (MCS). The aim of this study was to report our experience with CS requiring MCS in the peripartum period.MethodsWe present a single‐center retrospective analysis of all CS cases involving MCS during the peripartum period that occurred between 2012 and 2023.ResultsEleven cases were included. Median age was 33, median BMI was 30.4, and 73% underwent a caesarian‐section for delivery. CS presentation occurred in 36.4% during pregnancy and in 63.6% after delivery. Most patients were in Society for Cardiovascular Angiography & Interventions (SCAI) Stage C shock and in 37% the suspected etiology was peripartum cardiomyopathy. MCS usage included intra‐aortic balloon pump (4), Impella microaxial blood pump (2), veno‐arterial extracorporeal membrane oxygenation (6), and temporary right ventricle assist devices (2), with some patients having multiple MCS devices. The rate of major complications was 36.4%. During a median follow‐up of 4.5 years, 7 patients had sustained cardiac recovery (63.6%), 1 patient (9.1%) underwent cardiac transplantation, 2 patients (18.2%) received a durable LVAD, and 2 (18.2%) have died.ConclusionMCS in severe CS cases during the peripartum period is rare and associated with favorable outcomes. High recovery rates suggest favoring first MCS/LVAD over transplant.

show abstract

Mechanical Circulatory Support for Peripartum Cardiomyopathy: A Systematic Review

Cited by 4 publications

References 0 publications

Racial and Ethnic Disparities in the Trends and Outcomes of Cardiogenic Shock Complicating Peripartum Cardiomyopathy

Racial and Ethnic Disparities in the Trends and Outcomes of Cardiogenic Shock Complicating Peripartum Cardiomyopathy

Peripartum Cardiomyopathy

Mechanical circulatory support for cardiogenic shock during the peripartum period

Contact Info

Product

Resources

About